C183H227ClF4N32O2 — CID 159305167
5-tert-butyl-4-chloro-1H-indazole;5-tert-butyl-4-fluoro-1H-indazole;5-tert-butyl-6-fluoro-1H-indazole;4-(4-tert-butyl-2-fluorophenyl)-1H-pyrazole;4-(4-tert-butyl-3-fluorophenyl)-1H-pyrazole;5-tert-butyl-1H-indazole;6-tert-butyl-1H-indazole;4-(4-tert-butyl-2-methoxyphenyl)-1H-pyrazole;4-(4-tert-butyl-3-methoxyphenyl)-1H-pyrazole;5-tert-butyl-3-methyl-2H-indazole;5-tert-butyl-4-methyl-1H-indazole;4-(3-tert-butylphenyl)-1H-pyrazole;4-(4-tert-butylphenyl)-1H-pyrazole;2-tert-butyl-5-(1H-pyrazol-4-yl)pyridine;5-tert-butyl-2-(1H-pyrazol-4-yl)pyridine (PubChem CID 159305167) has the molecular formula C183H227ClF4N32O2 and a molecular weight of 3018.50 g/mol. Its IUPAC name is 5-tert-butyl-4-chloro-1H-indazole;5-tert-butyl-4-fluoro-1H-indazole;5-tert-butyl-6-fluoro-1H-indazole;4-(4-tert-butyl-2-fluorophenyl)-1H-pyrazole;4-(4-tert-butyl-3-fluorophenyl)-1H-pyrazole;5-tert-butyl-1H-indazole;6-tert-butyl-1H-indazole;4-(4-tert-butyl-2-methoxyphenyl)-1H-pyrazole;4-(4-tert-butyl-3-methoxyphenyl)-1H-pyrazole;5-tert-butyl-3-methyl-2H-indazole;5-tert-butyl-4-methyl-1H-indazole;4-(3-tert-butylphenyl)-1H-pyrazole;4-(4-tert-butylphenyl)-1H-pyrazole;2-tert-butyl-5-(1H-pyrazol-4-yl)pyridine;5-tert-butyl-2-(1H-pyrazol-4-yl)pyridine.
| Compound Name | 5-tert-butyl-4-chloro-1H-indazole;5-tert-butyl-4-fluoro-1H-indazole;5-tert-butyl-6-fluoro-1H-indazole;4-(4-tert-butyl-2-fluorophenyl)-1H-pyrazole;4-(4-tert-butyl-3-fluorophenyl)-1H-pyrazole;5-tert-butyl-1H-indazole;6-tert-butyl-1H-indazole;4-(4-tert-butyl-2-methoxyphenyl)-1H-pyrazole;4-(4-tert-butyl-3-methoxyphenyl)-1H-pyrazole;5-tert-butyl-3-methyl-2H-indazole;5-tert-butyl-4-methyl-1H-indazole;4-(3-tert-butylphenyl)-1H-pyrazole;4-(4-tert-butylphenyl)-1H-pyrazole;2-tert-butyl-5-(1H-pyrazol-4-yl)pyridine;5-tert-butyl-2-(1H-pyrazol-4-yl)pyridine |
|---|---|
| PubChem CID | 159305167 |
| Molecular Formula | C183H227ClF4N32O2 |
| Molecular Weight | 3018.50 g/mol |
| Exact Mass | 3015.83 |
| IUPAC Name | 5-tert-butyl-4-chloro-1H-indazole;5-tert-butyl-4-fluoro-1H-indazole;5-tert-butyl-6-fluoro-1H-indazole;4-(4-tert-butyl-2-fluorophenyl)-1H-pyrazole;4-(4-tert-butyl-3-fluorophenyl)-1H-pyrazole;5-tert-butyl-1H-indazole;6-tert-butyl-1H-indazole;4-(4-tert-butyl-2-methoxyphenyl)-1H-pyrazole;4-(4-tert-butyl-3-methoxyphenyl)-1H-pyrazole;5-tert-butyl-3-methyl-2H-indazole;5-tert-butyl-4-methyl-1H-indazole;4-(3-tert-butylphenyl)-1H-pyrazole;4-(4-tert-butylphenyl)-1H-pyrazole;2-tert-butyl-5-(1H-pyrazol-4-yl)pyridine;5-tert-butyl-2-(1H-pyrazol-4-yl)pyridine |
| SMILES | CC(C)(C)c1cc2cn[nH]c2cc1F.CC(C)(C)c1ccc(-c2cn[nH]c2)c(F)c1.CC(C)(C)c1ccc(-c2cn[nH]c2)cc1.CC(C)(C)c1ccc(-c2cn[nH]c2)cc1F.CC(C)(C)c1ccc(-c2cn[nH]c2)cn1.CC(C)(C)c1ccc(-c2cn[nH]c2)nc1.CC(C)(C)c1ccc2[nH]ncc2c1.CC(C)(C)c1ccc2[nH]ncc2c1Cl.CC(C)(C)c1ccc2[nH]ncc2c1F.CC(C)(C)c1ccc2cn[nH]c2c1.CC(C)(C)c1cccc(-c2cn[nH]c2)c1.COc1cc(-c2cn[nH]c2)ccc1C(C)(C)C.COc1cc(C(C)(C)C)ccc1-c1cn[nH]c1.Cc1[nH]nc2ccc(C(C)(C)C)cc12.Cc1c(C(C)(C)C)ccc2[nH]ncc12 |
| InChI | InChI=1S/2C14H18N2O.2C13H15FN2.2C13H16N2.2C12H15N3.2C12H16N2.C11H13ClN2.2C11H13FN2.2C11H14N2/c1-14(2,3)11-5-6-12(13(7-11)17-4)10-8-15-16-9-10;1-14(2,3)12-6-5-10(7-13(12)17-4)11-8-15-16-9-11;1-13(2,3)10-4-5-11(12(14)6-10)9-7-15-16-8-9;1-13(2,3)11-5-4-9(6-12(11)14)10-7-15-16-8-10;1-13(2,3)12-6-4-10(5-7-12)11-8-14-15-9-11;1-13(2,3)12-6-4-5-10(7-12)11-8-14-15-9-11;1-12(2,3)10-4-5-11(13-8-10)9-6-14-15-7-9;1-12(2,3)11-5-4-9(6-13-11)10-7-14-15-8-10;1-8-9-7-13-14-11(9)6-5-10(8)12(2,3)4;1-8-10-7-9(12(2,3)4)5-6-11(10)14-13-8;1-11(2,3)8-4-5-9-7(10(8)12)6-13-14-9;1-11(2,3)8-4-7-6-13-14-10(7)5-9(8)12;1-11(2,3)8-4-5-9-7(10(8)12)6-13-14-9;1-11(2,3)9-4-5-10-8(6-9)7-12-13-10;1-11(2,3)9-5-4-8-7-12-13-10(8)6-9/h2*5-9H,1-4H3,(H,15,16);2*4-8H,1-3H3,(H,15,16);2*4-9H,1-3H3,(H,14,15);2*4-8H,1-3H3,(H,14,15);2*5-7H,1-4H3,(H,13,14);3*4-6H,1-3H3,(H,13,14);2*4-7H,1-3H3,(H,12,13) |
| InChIKey | LBVFFTLNMAAYPH-UHFFFAOYSA-N |
| XLogP | 47.65 |
| TPSA | 474.44 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 222 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3018.50 |
| LogP ≤ 5 | 47.65 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 19 |